NCT03008590View on ClinicalTrials.gov

Low Dose Naltrexone for Chronic Pain From Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
OsteoarthritisArthritis, RheumatoidArthritis, Psoriatic
Interventions
DRUG

Naltrexone

One 4.5 mg capsule each evening

DRUG

Placebo

One capsule each evening

Trial Locations (1)

02130

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03008590 - Low Dose Naltrexone for Chronic Pain From Arthritis | Biotech Hunter | Biotech Hunter